By Gabe Sanders Ph.D., NSCA-CSCS The FDA has approved the immunotherapy which is designed to be dosed in three phases, an initial dose-escalation, then an up-dosing phase followed by the maintenance phase.
By Gabe Sanders Ph.D., NSCA-CSCS The FDA has approved the immunotherapy which is designed to be dosed in three phases, an initial dose-escalation, then an up-dosing phase followed by the maintenance phase.